Fabio
70 lines
3.2 KiB
Markdown
70 lines
3.2 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation"
|
||
description: "Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider; provides for accountability of such funds; provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing."
|
||
jurisdiction: "us/states/ny"
|
||
legislature: "New York Legislature"
|
||
session: "2021-2022"
|
||
identifier: "S 7837"
|
||
citation: "New York S 7837 (2021-2022)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["BRESLIN"]
|
||
version_count: 1
|
||
action_count: 11
|
||
vote_count: 3
|
||
first_action: "2022-01-12"
|
||
last_action: "2022-02-24"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/44b1e08d-d6ac-4882-9b1a-a2376c1eae6c"
|
||
source_url: "http://www.nysenate.gov/legislation/bills/2021/S7837"
|
||
source_hash: "2bbff41f822de397de6bcfe2e0a205a32c6503ab4186e634dca7d28c139029a8"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-ny"]
|
||
---
|
||
|
||
# New York S 7837 (2021-2022) — Provides for pharmacy benefit management and the procurement of prescription drugs at a negotiated rate for dispensation
|
||
|
||
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy in trust for the health plan or provider; provides for accountability of such funds; provides for an appeals process to investigate and resolve disputes regarding multi-source generic drug pricing.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **S7837** (committee substitute) — [source](http://assembly.state.ny.us/leg/?sh=printbill&bn=S7837&term=2021&Text=Y)
|
||
|
||
## Votes
|
||
|
||
- Floor Vote — **62–1** (pass) · upper
|
||
- Assembly Vote — **144–0** (pass) · lower
|
||
- Rules Vote — **20–1** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- BRESLIN — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2022-01-12** REFERRED TO RULES `referral-committee`
|
||
- **2022-01-18** ORDERED TO THIRD READING CAL.195
|
||
- **2022-01-19** PASSED SENATE `passage`
|
||
- **2022-01-19** DELIVERED TO ASSEMBLY
|
||
- **2022-01-19** REFERRED TO HEALTH `referral-committee`
|
||
- **2022-02-14** SUBSTITUTED FOR A8838
|
||
- **2022-02-14** ORDERED TO THIRD READING CAL.403
|
||
- **2022-02-14** PASSED ASSEMBLY `passage`
|
||
- **2022-02-14** RETURNED TO SENATE
|
||
- **2022-02-24** DELIVERED TO GOVERNOR `executive-receipt`
|
||
- **2022-02-24** SIGNED CHAP.128 `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/44b1e08d-d6ac-4882-9b1a-a2376c1eae6c`. Confidence: reported (aggregated from official New York legislature records).
|
||
|